-
1
المؤلفون: Roboz GJ, Yee K, Verma A, Borthakur G, de la Fuente Burguera A, Sanz G, Mohammad HP, Kruger RG, Karpinich NO, Ferron-Brady G, Acusta A, Del Buono H, Collingwood T, Ballas M, Dhar A, Wei AH
المصدر: Leukemia & lymphoma
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname -
2مورد إلكتروني
المؤلفون: Roboz, GJ, Yee, K, Verma, A, Borthakur, G, de la Fuente Burguera, A, Sanz, G, Mohammad, HP, Kruger, RG, Karpinich, NO, Ferron-Brady, G, Acusta, A, Del Buono, H, Collingwood, T, Ballas, M, Dhar, A, Wei, AH
مصطلحات الفهرس: Journal Article
-
3دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
4دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
5دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
6دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
7دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
8دورية أكاديمية
المؤلفون: Hilton JF; The Ottawa Hospital Cancer Centre, Ottawa, ON, Canada., Ott PA; Dana Farber Cancer Institute, Boston, MA, USA., Hansen AR; Princess Margaret Cancer Centre, Toronto, ON, Canada., Li Z; New York University, New York, NY, USA., Mathew M; Columbia University Irving Medical Center, New York, NY, USA., Messina CH; GSK, Collegeville, PA, USA., Dave V; GSK, Bengaluru, Karnataka, India., Ji X; GSK, Collegeville, PA, USA., Karpinich NO; GSK, Collegeville, PA, USA., Hirschfeld S; GSK, Collegeville, PA, USA., Ballas M; GSK, Collegeville, PA, USA., Zandberg DP; UPMC Hillman Cancer Center, 5150 Centre Avenue, Pittsburgh, PA, 15232, USA. zandbergdp@upmc.edu.
المصدر: Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2024 Feb 13; Vol. 73 (3), pp. 44. Date of Electronic Publication: 2024 Feb 13.
نوع المنشور: Clinical Trial, Phase II; Clinical Trial, Phase I; Journal Article
بيانات الدورية: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 8605732 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-0851 (Electronic) Linking ISSN: 03407004 NLM ISO Abbreviation: Cancer Immunol Immunother Subsets: MEDLINE
-
9دورية أكاديمية
المؤلفون: Dawson MA; Department of Clinical Haematology, Peter MacCallum Cancer Centre, Royal Melbourne Hospital, Melbourne, Victoria, Australia.; The Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia., Borthakur G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Huntly BJP; University of Cambridge, Cambridge, United Kingdom., Karadimitris A; Hugh and Josseline Langmuir Centre for Myeloma Research, Centre for Haematology, Department of Immunology and Inflammation, Imperial College London and Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, United Kingdom., Alegre A; Hospital Universitario de La Princesa and Quironsalud, Madrid, Spain., Chaidos A; Hugh and Josseline Langmuir Centre for Myeloma Research, Centre for Haematology, Department of Immunology and Inflammation, Imperial College London and Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, United Kingdom., Vogl DT; Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania., Pollyea DA; University of Colorado School of Medicine, Aurora, Colorado., Davies FE; Perlmutter Cancer Center, NYU Langone Medical Center, New York, New York., Morgan GJ; Perlmutter Cancer Center, NYU Langone Medical Center, New York, New York., Glass JL; Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, New York., Kamdar M; University of Colorado School of Medicine, Aurora, Colorado., Mateos MV; Hospital Universitario de Salamanca, IBSAL, CIBERONC, Salamanca, Spain., Tovar N; Hospital Clínic, University of Barcelona, Barcelona, Spain., Yeh P; Department of Clinical Haematology, Peter MacCallum Cancer Centre, Royal Melbourne Hospital, Melbourne, Victoria, Australia.; The Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia., Delgado RG; Hospital Virgen de la Victoria, Málaga, Spain., Basheer F; Addenbrooke's Hospital, Cambridge, United Kingdom., Marando L; University of Cambridge, Cambridge, United Kingdom., Gallipoli P; Addenbrooke's Hospital, Cambridge, United Kingdom., Wyce A; GSK, Collegeville, Pennsylvania., Krishnatry AS; GSK, Collegeville, Pennsylvania., Barbash O; GSK, Collegeville, Pennsylvania., Bakirtzi E; GSK, Collegeville, Pennsylvania., Ferron-Brady G; GSK, Collegeville, Pennsylvania., Karpinich NO; GSK, Collegeville, Pennsylvania., McCabe MT; GSK, Collegeville, Pennsylvania., Foley SW; GSK, Collegeville, Pennsylvania., Horner T; GSK, Collegeville, Pennsylvania., Dhar A; GSK, Collegeville, Pennsylvania., Kremer BE; GSK, Collegeville, Pennsylvania., Dickinson M; Department of Clinical Haematology, Peter MacCallum Cancer Centre, Royal Melbourne Hospital, Melbourne, Victoria, Australia.; The Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia.
المصدر: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2023 Feb 16; Vol. 29 (4), pp. 711-722.
نوع المنشور: Clinical Trial, Phase II; Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't
بيانات الدورية: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE
مواضيع طبية MeSH: Lymphoma, Non-Hodgkin*/drug therapy , Hematologic Neoplasms*/drug therapy , Leukemia, Myeloid, Acute*/drug therapy , Thrombocytopenia*, Humans
-
10دورية أكاديمية
المؤلفون: Wyce A; Cancer Epigenetics DPU, Oncology R&D, GlaxoSmithKline, Collegeville, PA, USA., Matteo JJ; Cancer Epigenetics DPU, Oncology R&D, GlaxoSmithKline, Collegeville, PA, USA., Foley SW; Cancer Epigenetics DPU, Oncology R&D, GlaxoSmithKline, Collegeville, PA, USA., Felitsky DJ; Target Sciences, GlaxoSmithKline, Upper Merion, PA, USA., Rajapurkar SR; Cancer Epigenetics DPU, Oncology R&D, GlaxoSmithKline, Collegeville, PA, USA., Zhang XP; Cancer Epigenetics DPU, Oncology R&D, GlaxoSmithKline, Collegeville, PA, USA., Musso MC; Cancer Epigenetics DPU, Oncology R&D, GlaxoSmithKline, Collegeville, PA, USA., Korenchuk S; Cancer Epigenetics DPU, Oncology R&D, GlaxoSmithKline, Collegeville, PA, USA., Karpinich NO; Cancer Epigenetics DPU, Oncology R&D, GlaxoSmithKline, Collegeville, PA, USA., Keenan KM; Cancer Epigenetics DPU, Oncology R&D, GlaxoSmithKline, Collegeville, PA, USA., Stern M; Cancer Epigenetics DPU, Oncology R&D, GlaxoSmithKline, Collegeville, PA, USA., Mathew LK; Cancer Epigenetics DPU, Oncology R&D, GlaxoSmithKline, Collegeville, PA, USA., McHugh CF; Cancer Epigenetics DPU, Oncology R&D, GlaxoSmithKline, Collegeville, PA, USA., McCabe MT; Cancer Epigenetics DPU, Oncology R&D, GlaxoSmithKline, Collegeville, PA, USA., Tummino PJ; Cancer Epigenetics DPU, Oncology R&D, GlaxoSmithKline, Collegeville, PA, USA.; Janssen Pharmaceuticals, Spring House, Montgomery, PA, USA., Kruger RG; Cancer Epigenetics DPU, Oncology R&D, GlaxoSmithKline, Collegeville, PA, USA., Carpenter C; Cancer Epigenetics DPU, Oncology R&D, GlaxoSmithKline, Collegeville, PA, USA., Barbash O; Cancer Epigenetics DPU, Oncology R&D, GlaxoSmithKline, Collegeville, PA, USA. olena.x.barbash@gsk.com.
المصدر: Oncogenesis [Oncogenesis] 2018 Apr 20; Vol. 7 (4), pp. 35. Date of Electronic Publication: 2018 Apr 20.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101580004 Publication Model: Electronic Cited Medium: Print ISSN: 2157-9024 (Print) Linking ISSN: 21579024 NLM ISO Abbreviation: Oncogenesis Subsets: PubMed not MEDLINE